Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists.
Boeckmans J, Natale A, Rombaut M, Buyl K, Cami B, De Boe V, Heymans A, Rogiers V, De Kock J, Vanhaecke T, Rodrigues RM.
Boeckmans J, et al. Among authors: cami b.
Cell Biol Toxicol. 2021 Apr;37(2):293-311. doi: 10.1007/s10565-020-09544-2. Epub 2020 Jul 1.
Cell Biol Toxicol. 2021.
PMID: 32613381